Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial. - Martínez E; Watanabe M; Hoffman R; Zanni MV; Pozniak A; Shakil SS; McCallum S; Chu SM; Srinivasa S; Malvestutto CD; Fichtenbaum CJ; Bloomfield GS; et al. (The lancet. HIV, 2026)